Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSK3B | P49841 | 14/20 | 0.62 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.50 |
| ▸ | CDK2 | P24941 | 3/20 | 0.46 |
| ▸ | CDK9 | P50750 | 2/20 | 0.46 |
| ▸ | CCNT1 | O60563 | 1/20 | 0.46 |
| ▸ | CCNE1 | P24864 | 2/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13305374 | 0.90 | GSK3B (0.61) | GSK3BCHEK1CDK2CDK9CCNT1 | |
| SCHEMBL12952894 | 0.90 | GSK3B (0.78) | GSK3BCDK2CCNE1 | |
| SCHEMBL14418828 | 0.90 | GSK3B (0.57) | GSK3BCHEK1CDK2 | |
| SCHEMBL13116990 | 0.90 | GSK3B (0.59) | GSK3BCHEK1CDK2CCNE1 | |
| SCHEMBL14613487 | 0.88 | GSK3B (0.56) | GSK3BCHEK1CDK2 | |
| SCHEMBL14418829 | 0.87 | GSK3B (0.56) | GSK3BCHEK1CDK2CCNE1 | |
| SCHEMBL14050830 | 0.87 | GSK3B (0.68) | GSK3BCHEK1CDK2CCNE1 | |
| SCHEMBL13304983 | 0.85 | GSK3B (0.61) | GSK3BCHEK1CDK2CCNE1 | |
| SCHEMBL13304607 | 0.84 | GSK3B (0.79) | GSK3BCHEK1CDK2CCNE1 | |
| SCHEMBL14545273 | 0.84 | GSK3B (0.52) | GSK3BCHEK1CDK2CCNE1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1537116-B1 | PYRAZOLOPYRIMIDINES SUITABLE FOR THE TREATMENT OF CANCER DISEASES | SCHERING CORP (US) | 2010-06-02 | — | — | EP | disclosed |